Abstract
Background
Smoking is a well-established risk factor for bladder cancer. However, it remained unclear that whether smoke status and smoke frequency increase bladder cancer.
Objective
We aim to explore the causal relationship between smoking status, smoking frequency and the risk of bladder cancer by Mendelian randomization.
Methods
Large sample size of the genome-wide association(GWAS) database of smoking status, smoking frequency and bladder cancer were obtained. Smoking status included never, previous and current whereas smoking frequency included cigarettes smoked per day, number of cigarettes currently smoked daily and pack years of smoking. Six sets of instrumental variables and 78 related single nucleotide polymorphic(SNP) loci were identified (P < 5 × 10–8. Linkage disequilibrium R2 < 0.001). The causal relationship between smoking status and bladder tumor was studied by inverse variance weighted (IVW), weighted median and MR-Egger regression. Sensitivity analysis were also performed.
Results
There is no causal effect from smoke status on bladder cancer risk while significantly positive relationship between smoking frequency on bladder cancer risk were found. IVW results showed that cigarettes smoked per day, number of cigarettes currently smoked daily and pack years of smoking increase bladder cancer (OR 1.001, 95% CI 1.000–1.002, P = 0.047; OR 1.003, 95% CI 1.000–1.005, P = 0.028; OR 1.004, 95% CI 1.001–1.006, P = 0.003). Sensitivity analysis showed that genetic pleiotropy did not bias the results.
Conclusion
The results of two sample Mendelian randomization analysis show that there is a positive causal relationship between smoking frequency and the risk of bladder cancer.
Similar content being viewed by others
Data availability
Some or all data generated or analyzed were all publicly available.
References
Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P, Jarvis MJ, Joseph A, Oncken C, Piper ME (2020) Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tob Res 22:1086
Bohm F, Schmid D, Denzinger S, Wieland WF, Richter E (2011) DNA adducts of ortho-toluidine in human bladder. Biomarkers 16:120–128
Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–525
Bowden J, Davey SG, Haycock PC, Burgess S (2016) Consistent estimation in mendelian randomization with Some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314
Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658–665
Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG (2017) Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology 28(1):30–42
Catsburg CE, Gago-Dominguez M, Yuan JM, Castelao JE, Cortessis VK, Pike MC, Stern MC (2014) Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. Int J Cancer 134:125–135
Chen X, Kong JQ, Pan JX, Huang K, Zhou WH, Diao XY, Cai JH, Zheng JJ, Yang XF, Xie WB et al (2021) Kidney damage causally affects the brain cortical structure: a Mendelian randomization study. EBioMedicine 72:103592
Creamer MR, Wang TW, Babb SD, Cullen KA, Day H, Willis G, Jamal A, Neff LJ (2019) Tobacco product use and cessation indicators among adults—United States, 2018. MMWR Morb Mortal Wkly Rep 68(45):1013–1019
Cumberbatch MG, Rota M, Catto JW, La Vecchia C (2016) The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol 70(3):458–466
Deininger S, Hennenlotter J, Rausch S, Docktor K, Neumann E, da Costa IA, Bedke J, Stenzl A, Todenhöfer T (2018) No influence of smoking status on the performance of urine markers for the detection of bladder cancer. J Cancer Res Clin Oncol 144:1367–1373
Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7):737–745
Garcia CR, Garcia CM, Kogevinas M, Malats N, Silverman D, Serra C, Tardón A, Carrato A, Gemma CV, Dosemeci M et al (2007) Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer 43:1731–1740
Glaser AP, Fantini D, Shilatifard A, Schaeffer EM, Meeks JJ (2017) The evolving genomic landscape of urothelial carcinoma. Nat Rev Urol 14:215–229
Glaser AP, Fantini D, Wang Y, Yanni Y, Rimar KJ, Podojil JR, Miller SD, Meeks JJ (2018) APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response. Oncotarget 9:4537–4548
Gronau QF, Wagenmakers EJ (2019) Limitations of Bayesian leave-one-out cross-validation for model selection. Comput Brain Behav 2(1):1–11
Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM (2016) Current cigarette smoking among adults—United States, 2005–2015. MMWR Morb Mortal Wkly Rep 65(44):1205–1211
Kanai M, Akiyama M, Takahashi A, Matoba N, Momozawa Y, Ikeda M, Iwata N, Ikegawa S, Hirata M, Matsuda K et al (2018) Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet 50(3):390–400
Konorev D, Koopmeiners JS, Tang Y, Thompson EAF, Jensen JA, Hatsukami DK, Turesky RJ (2015) Measurement of the heterocyclic amines 2-amino-9H-pyrido [2,3-b] indole and 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine in urine: effects of cigarette smoking. Chem Res Toxicol 28:2390–2399
Larsson SC, Burgess S (2022) Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of Mendelian randomization studies. Ebio Medicine 82:104154
Matulewicz RS, Ravvaz K, Weissert JA, Porten S, Steinberg GD, Blue Light Cystoscopy with Cysview Registry Group (2021) Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with bluelight cystoscopy. Urol Oncol 39:833.e19
Matulewicz RS, Basak R, Zambrano I, Dearing BA, Schatz D, Shahawy OE, Sherman S, Bjurlin MA (2021) Patterns of current cigarette smoking, quit attempts and cessation counselling among survivors of smoking-related and non smoking-related urological malignancies: a nationally representative cross-sectional analysis. J Urol 205:1444
Murta NC, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX, Malats N (2007) Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World J Urol 25:285–295
Ong JS, Mac Gregor S (2019) Implementing MR-PRESSO and GCTA-GSMR for pleiotropy assessment in Mendelian randomization studies from a practitioner’s perspective. Genet Epidemiol 43(6):609–616
Safiri S, Kolahi AA, Naghavi M, Global Burden of Disease Bladder Cancer Collaborators (2021) Global Burden of Disease Bladder Cancer Collaborators. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019. BMJ Glob Health 6(11):e004128
Slob EAW, Groenen PJF, Thurik AR, Rietveld CA (2017) A note on the use of Egger regression in Mendelian randomization studies. Int J Epidemiol 46(6):2094–2097
Thong AE, Petruzella S, Orlow I, Zabor EC, Ehdaie B, Ostroff JS, Bochner BH, Barnes HF (2016) Accuracy of self-reported smoking exposure among bladder cancer patients undergoing surveillance at atertiary referral center. Eur Urol Focus 2:441
Van Osch FHM, Jochems SHJ, Reulen RC, Pirrie SJ, Nekeman D, Wesselius A, James AD, Wallace DMA, Cheng KK, Schooten FJV et al (2018) The association between smoking cessation before and after diagnosis and non-muscle invasive bladder cancer recurrence: a prospective cohort study. Cancer Causes Control 29:675
Zaitsu M, Lee HE, Lee S, Takeuchi T, Kobayashi Y, Kawachi I (2020) Occupational disparities in bladder cancer survival: a population-based cancer registry study in Japan. Cancer Med 9(3):894–901
Zhao X, Wang Y, Liang C (2022) Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis. Int Urol Nephrol 54(6):1169–1185
Acknowledgements
The authors thank all investigators of the IEU OpenGwas project. The GWAS data used in our study were downloaded from https://gwas.mrcieu.ac.uk/datasets.
Funding
The study was funded by Health Commission of Shanxi Province (Grant no. 2022073).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Lei Pang, Zijun Ding, Hongqiang Chai, Fei Li, Ming Wu and Weibing Shuang declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pang, L., Ding, Z., Chai, H. et al. Causal relationship between smoking status, smoking frequency and bladder cancer: a Mendelian randomization study. Genes Genom 45, 203–213 (2023). https://doi.org/10.1007/s13258-022-01346-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-022-01346-6